SEREVENT
Prescription medicines
SEREVENT
Product information:
SEREVENT product monograph
Health-care Professional Information:
September 7, 2005 - New safety information regarding SEREVENT
August 15, 2003 - Important safety information regarding SEREVENT (salmeterol xinafoate) inhalation aerosol
Patient information:
October 4, 2005 - safety information about a class of asthma drugs known as long-acting beta-2 agonists
September 4, 2003 - Important safety information regarding SEREVENT (salmeterol xinafoate) inhalation aerosol
Trademarks are owned by or licensed to the GSK group of companies.